Lanzatech New Zealand Limited

Caldera Health Limited

Arborgen, LLC

Richard Llewellyn Sydney Forster

Sean Dennis Simpson

James Douglas Watson

Christophe Collet

Matthew Rowe

Damian Jay White

Phuong Loan Tran

William Horn Rottmann

Leonard N Bloksberg

Ilkka Havukkala

Michael Charles Milner Cockrem

Marie B Connett

Catherine Jane Bryant

Colleen M Higgins

Sarah Jane Emerson

Jonathan Phillips

Murray Robert Grigor

Michael J Frost

Simon David Oakley

Marion Wood

Steven Troy Lund

Andreas Magusin

Katrina Gause

Annette Lasham

Claire Westwood

Stella Veerakone

Ian Linstrand Warner

Sathiah Puthigae

Michael Koepke

Sathish Puthigae

Bakir Al-Sinawi

Jennifer Mon Yee Fung

Michael Kopke

Gary Chan

Kelly Marie Mahar

Matthew James Rowe

Loan Tran Phuong

The invention provides polynucleotide sequences isolated from plants encoding transcription factors. Polypeptides encoded by the polynucleotides are also provided. Products and methods of use are disclosed.

Transcription factors

A biologically pure isolate of a selected bacterium derived fromis described which has improved efficiency in the production of ethanol by anaerobic fermentation of substrates comprising carbon monoxide. The bacterium can produce ethanol and acetate at an ethanol to acetate ratio of at least 1.0 and has a productivity of at least 1.2 g of ethanol/l of fermentation broth per day. The bacterium is also characterized in that it has substantially no ability to sporulate.

Bacteria and methods of use thereof

The present disclosure provides methods for selecting a treatment composition, or therapy, for the treatment of a cancer, such as prostate or breast cancer, in a patient wherein the treatment composition includes administering a combination of at least two components selected from two different classes of compounds. Methods for treating a patient using the selected treatment composition are also provided, together with methods for monitoring the efficacy of the treatment composition during a treatment period.

Methods for determining personalized treatment compositions for prostate cancer and breast cancer

Methods for diagnosing the presence of prostate cancer in a subject are provided, such methods including detecting the levels of expression of multiple polypeptide biomarkers in a biological sample obtained from the subject and comparing the levels of expression with predetermined threshold levels. Levels of expression of at least two of the polypeptide markers that are above the predetermined threshold levels are indicative of the presence of prostate cancer in the subject. Determination of the expression levels of specific combinations of biomarkers can also be used to determine the type and/or stage of prostate cancer.

Methods and materials for the diagnosis of prostate cancers

Methods for monitoring, and determining the efficacy of, a treatment for prostate cancer in a subject are provided, such methods including detecting the levels of expression of multiple polypeptide biomarkers in biological samples obtained from the subject prior to, and during, a course of treatment. Specific patterns of changes in the expression of the polypeptide biomarkers are indicative of the effectiveness of the treatment in the subject.

Methods and materials for determining the efficacy of prostate cancer therapies

The invention relates to methods of capturing carbon by microbial fermentation of a gaseous substrate comprising CO. The methods of the invention include converting CO to one or more products including alcohols and/or acids and optionally capturing CO2 to improve overall carbon capture. In certain aspects, the invention relates to processes for producing alcohols, particularly ethanol, from industrial waste streams, particularly steel mill off-gas.

Carbon capture in fermentation

The invention relates to processes for converting CO by microbial fermentation to one or more products including alcohols and/or acids and optionally capturing COto improve overall carbon capture. More particularly the invention relates to a method for producing one or more products from a CO comprising substrate, the method comprising a natural gas reforming step for producing a syngas stream, and converting at least a portion of CO from the syngas stream to one or more products including ethanol.

The invention relates to biological processes for producing one or more desired products, including alcohols such as ethanol and butanol. The processes comprise carrying out first and second fermentations of substrates in first and second bioreactors, wherein each fermentation produces one or more desired products and/or one or more by-products that can be utilized in the other fermentation. A product and/or by-product of the first fermentation is introduced to the second bioreactor during the fermentation, and a product and/or by-product of the second fermentation is introduced to the first bioreactor during the fermentation.

Alcohol production process

A novel class of bacteria is described which has improved efficiency in the production of thanol by anaerobic fermentation of substrates containing carbon monoxide.

The invention relates to methods for the production of alcohols by microbial fermentation, particularly microbial fermentation of substrates comprising glycerol and/or acetate, to butanol.

The invention relates to the production of alcohols by microbial fermentation, particularly to production of alcohols by microbial fermentation of substrates comprising CO. It more particularly relates to processes for the production of alcohols from their corresponding acids in the presence of a substrate comprising CO. In particular embodiments, a fermentation reaction producing acid(s) and optionally alcohol(s) is perturbed such that at least a portion one or more of acid(s) is converted to alcohol.

Microbial alcohol production process

Growing community of inventors

Pukekohe, New Zealand

Richard Llewellyn Sydney Forster